Report of Foreign Issuer (6-k)
February 06 2018 - 10:55AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE
ISSUER
PURSUANT TO RULE 13a-16
OR 15d-16 OF
THE SECURITIES EXCHANGE
ACT OF 1934
For the month of February,
2018
Commission File Number 000-28996
ELBIT IMAGING LTD.
(Translation of Registrant’s
Name into English)
3 SHIMSHON STREET, PETACH
TIKVA, ISRAEL
(Address of principal executive
offices)
Indicate by check mark whether
the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
Indicate by check mark if
the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark if
the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
THIS REPORT ON FORM 6-K IS
HEREBY INCORPORATED BY REFERENCE INTO ELBIT IMAGING LTD.’S REGISTRATION STATEMENT ON FORM F-1 (REGISTRATION STATEMENTS NO.
333-194519), REGISTRATION STATEMENT ON FORM F-3 (REGISTRATION STATEMENT NO. 333-172122) AND REGISTRATION STATEMENTS ON FORM S-8
(REGISTRATION STATEMENTS NOS. 333-117509, 333-130852, 333-136684 AND 333-152820), AND TO BE A PART THEREOF FROM THE DATE ON WHICH
THIS REPORT IS SUBMITTED, TO THE EXTENT NOT SUPERSEDED BY DOCUMENTS OR REPORTS SUBSEQUENTLY FILED OR FURNISHED.
CONTENTS
Elbit Medical Technologies
Ltd. ("
Elbit Medical
"), informed the Company that it published second drafts of the relevant documents for a possible
issuance on the Tel Aviv Stock Exchange of a new series of notes convertible into ordinary shares of Elbit Medical and secured
by a lien on a portion of Elbit Medical’s holdings in INSIGHTEC Ltd. and Gamida Cell Ltd.
As of the date hereof, there
is no certainty that Elbit Medical will actually raise debt financing or on what terms. The issuance of securities by Elbit Medical
is subject, among other things, to the existence of appropriate market conditions and receipt of all approvals required by law,
including the approval of Elbit Medical’s Board of Directors and the approval of the Tel Aviv Stock Exchange and the Israeli
Securities Authority.
The
securities being offered by Elbit Medical Technologies Ltd. will not be registered under the U.S. Securities Act of 1933 and will
not be offered or sold in the United States absent registration or an applicable exemption from registration requirements
of the U.S. Securities Act of 1933. This Form 6-K shall not constitute an offer to sell or the solicitation of an offer to buy
any securities.
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
ELBIT IMAGING LTD.
(Registrant)
|
|
|
|
|
Date: February 6, 2018
|
|
By:
|
/s/ Ron Hadassi
|
|
|
|
Ron Hadassi
CEO & Chairman of the Board of Directors
|
Elbit Imaging (CE) (USOTC:EMITF)
Historical Stock Chart
From Aug 2024 to Sep 2024
Elbit Imaging (CE) (USOTC:EMITF)
Historical Stock Chart
From Sep 2023 to Sep 2024